Safety and predictors of stroke mimics in The Norwegian Tenecteplase Stroke Trial (NOR-TEST)

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

(2017) Nicola Logallo et al.   LANCET NEUROLOGY

NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study)

(2016) Aliona Nacu et al.   STROKE

FABS

(2016) Nitin Goyal et al.   STROKE

Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study

(2015) Xuya Huang et al.   LANCET NEUROLOGY

Mild stroke: safety and outcome in patients receiving thrombolysis

(2014) N. Logallo et al.   ACTA NEUROLOGICA SCANDINAVICA

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke

(2014) Nicola Logallo et al.   BMC Neurology

Thrombolysis in Patients With Mild Stroke

(2014) Stefan Greisenegger et al.   STROKE

The TeleStroke Mimic (TM)‐Score: A Prediction Rule for Identifying Stroke Mimics Evaluated in a Telestroke Network

(2014) Syed F. Ali et al.   Journal of the American Heart Association

Predictors of Acute Stroke Mimics in 8187 Patients Referred to a Stroke Service

(2013) José G. Merino et al.   Journal of Stroke & Cerebrovascular Diseases

Safety of Thrombolysis in Stroke Mimics

(2013) Sanne M. Zinkstok et al.   STROKE

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

(2013) Edward C. Jauch et al.   STROKE

Stroke Mimics Treated with Thrombolysis: Further Evidence on Safety and Distinctive Clinical Features

(2012) Marta Guillan et al.   CEREBROVASCULAR DISEASES

How to identify stroke mimics in patients eligible for intravenous thrombolysis?

(2012) A. Förster et al.   JOURNAL OF NEUROLOGY

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

(2012)   LANCET

A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke

(2012) Mark Parsons et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Model to Prevent Fibrinolysis in Patients with Stroke Mimics

(2011) Jason Chang et al.   Journal of Stroke & Cerebrovascular Diseases

Safety and Outcomes of Intravenous Thrombolysis in Stroke Mimics

(2011) Georgios Tsivgoulis et al.   STROKE

Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia

(2010) O. Y. Chernyshev et al.   NEUROLOGY

Thrombolysis in Stroke Mimics

(2009) David T. Winkler et al.   STROKE

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

(2008)   CEREBROVASCULAR DISEASES

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE